SLNO 8-K 2026-01-12

SOLENO THERAPEUTICS INC (SLNO) 8-K dated 2026-01-12 — accession 0001193125-26-009886. This URL is the filing, not the SLNO hub.

SOLENO THERAPEUTICS INC (SLNO) is a biotechnology company listed on NASDAQ.

SOLENO THERAPEUTICS INC filed a 8-K on 2026-01-12. Accession 0001193125-26-009886.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SLNO revenue for 2026-03-31 was $94.6M. Net income was $31.4M. Revenue was up 43.3% from 2025-09-30 to 2026-03-31. SLNO currently screens at market cap $2.76B and trailing P/E 27.5.

Not investment advice. The SLNO SEC hub lists recent forms. The stock page is the research view.